Epilepsyusa08 - Issue4

In This Issue...


backtoschool_issue4Getting Ready for Back to School: Seizure Management for Students

As many as 325,000 school-age children, ages 5–14, have epilepsy. Thankfully, with medication, surgery, a special diet or vagus nerve stimulation, most go to school and fully participate in school activities.

By Eileen Frueh, special to EpilepsyUSA

Epilepsy in African American CommunityEpilepsy in the African American Community: Access, Education, Advocacy

Lance Curtis may be an anomaly. As an African-American with epilepsy, he is part of a group that often faces some of the most serious challenges in epilepsy treatment.

By Aliyah Baruchin, Special to EpilepsyUSA

denisep_issue4

In My Own Words

"I went from being a vibrant woman with a bright future tobeing a candidate for an extended adult care facility. The world had once been my oyster, and the oyster just closed right up."


By Denise Pease

ADHD and EpilepsyADHD and Epilepsy

Children with attention deficit hyperactivity disorder (ADHD) and their parents are frequent visitors to the offices of pediatric neurologists.

By Andrew N. Wilner, MD, FACP, FAAN

Epilepsy in the WorkplaceEpilepsy in the Workplace: To Disclose or Not?

People with epilepsy are often confronted with the issue of whether they are required to disclose information about their health condition to their employers.



By Gary Gross, Special to EPILEPSYUSA

Epilepsy in PerspectiveEpilepsy in Perspective

Clearly Nick's way of looking at things−from epilepsy, to images in front of his camera, to a damaged lampost−provides him with a unique angle that helps topple conventional viewpoints and preconceived notions.

By Lisa Boylan, Editor, EPILEPSYUSA

CampCamp Provides Opportunity for Kids with Epilepsy

A summer camp experience can be life-changing event in a child's life, but for many years, children living with epilepsy did not have that experience.

By Andria Farrell, Special to EPILEPSYUSA

schoolAdministration of Medication and Other Treatments in Schools, Daycare and Camps

There are multiple situations in which people with epilepsy who are prescribed FDAapproved treatments, such as rectally administered diazepam (Diastat®) or the VNS (vagus nerve stimulator), have been denied access to school, daycare or school-related activities, or have incurred unnecessary medical risks because educators and child care service providers refuse to make the medications readily available on-site.


cover_inside_issue4
Download the Current Issue (PDF)



Steve Sabatini, EpilepsyUSAMessage from the Chair
Steve Sabatini, Chair of the Epilepsy Foundation.